BMC Cell Biol 14:19
Semaglutide is FDA-approved for type 2 diabetes at 0.5 mg and 1.0 mg weekly (Ozempic prescribing information, Novo Nordisk, 2023)
Experts say the benefits are likely linked to reduced inflammation and improved blood sugar control, as well as possible effects on pain pathways
Rev Endocr Metab Disord 23(3):52139 Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S et al (2023) Semaglutide and cardiovascular outcomes in obesity without diabetes
Journal of Sexual Medicine, 15(12), 1816-1824
After four weeks, patients increase to 0.5mg weekly for another four weeks, then to the maintenance dose of 1mg or 2mg weekly depending on response and tolerance